Kiniksa Pharmaceuticals International Ratios (2021-2025) | KNSA

Ratios Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 77.12%79.37%86.89%81.35%93.00%104.52%98.98%89.23%86.45%88.51%86.75%88.66%82.08%85.40%87.03%88.14%88.80%
EBT Margin -253.51%-233.66%-72.34%-71.43%47.14%-61.30%-19.37%-1.73%-12.68%-86.37%-17.88%2.12%-6.42%-13.86%11.30%14.59%15.02%
EBIT Margin -253.55%-192.75%-72.44%-71.81%46.82%-4.08%-23.16%-4.41%-16.30%0.10%-20.71%-0.11%-8.61%-15.75%9.63%12.86%13.28%
EBITDA Margin -253.13%-193.94%-78.43%-74.03%226.07%-3.09%-25.36%20.89%-20.69%30.27%-22.24%-3.67%-11.23%-7.35%6.20%11.44%10.14%
Operating Margin -253.55%-192.75%-72.44%-71.81%46.82%-4.08%-23.16%-4.41%-16.30%0.10%-20.71%-0.11%-8.61%-15.75%9.63%12.86%13.28%
Net Margin -252.53%-235.15%-78.32%-74.08%226.05%-59.70%-25.38%20.95%-20.66%-59.05%-22.17%-3.60%-11.31%-7.25%6.20%11.37%10.19%
FCF Margin -236.13%-102.08%-114.47%-29.01%62.57%7.78%-8.88%-5.28%25.31%5.12%4.86%4.69%-2.01%15.26%16.13%17.76%18.29%
Efficiency
Inventory Average 4.29M5.99M4.64M8.45M16.57M17.27M18.11M22.51M23.69M24.77M28.35M29.20M31.07M31.77M27.52M24.22M35.12M44.79M
Assets Average 295.18M266.03M242.83M231.88M220.77M335.26M459.81M451.27M463.60M483.70M504.69M523.00M531.05M548.86M567.93M589.94M630.24M686.74M
Equity Average 253.24M224.92M199.54M175.64M159.87M268.75M390.08M393.12M400.88M408.39M421.98M435.37M433.50M436.05M437.72M447.96M476.25M515.20M
Invested Capital 270.70M235.78M214.05M185.04M166.24M153.49M384.01M396.15M390.10M411.66M405.13M438.84M431.89M435.10M437.01M438.44M457.49M495.01M535.38M
Asset Utilization Ratio 0.410.530.020.060.150.080.540.580.640.700.750.820.840.87
Leverage & Solvency
Equity Ratio 0.870.840.850.790.720.730.830.860.880.850.840.830.830.800.790.760.760.750.75
Valuation
Enterprise Value 854.79M641.28M570.29M628.62M459.07M489.17M666.32M850.98M653.47M726.77M934.46M1,027.36M1,107.21M986.21M1,430.20M1,184.52M1,233.88M1,595.58M2,348.25M
Market Capitalization 1,262.98M925.06M780.48M810.82M686.90M671.28M892.01M1,041.59M947.84M984.19M1,218.80M1,233.73M1,393.23M1,324.45M1,780.38M1,428.15M1,613.43M2,019.11M2,877.60M
Return Ratios
Return on Sales -1.33%0.76%26.74%10.72%4.46%2.01%-0.22%-0.22%-0.25%-0.22%-0.10%-0.04%0.01%0.06%
Return on Capital Employed -0.79%-0.72%-0.62%-0.12%0.02%0.05%0.09%-0.04%-0.06%-0.07%-0.06%-0.06%-0.10%-0.03%0.01%0.07%
Return on Invested Capital -0.04%-0.05%-0.06%-0.06%0.00%0.05%
Return on Assets -0.68%-0.61%-0.54%0.40%0.58%0.62%0.68%0.16%-0.12%-0.13%-0.16%-0.15%-0.08%-0.03%0.01%0.05%
Return on Equity -0.83%-0.81%-0.75%0.50%0.69%0.71%0.79%0.19%-0.14%-0.15%-0.20%-0.19%-0.10%-0.04%0.01%0.07%